best performing mid stocks from december 23 2019 to feb 04 2020

Immunitybio (IBRX) had the highest return between December 23, 2019 and February 4, 2020 by a mid-cap US stock, returning 107.3%.

ASSET DATE % RETURN
Immunitybio (IBRX)
12/23/2019 - 2/4/2020
107.32%
Nio Inc Class A ADR (NIO)
12/23/2019 - 2/4/2020
64.6%
TG Therapeutics (TGTX)
12/23/2019 - 2/4/2020
49.8%
Bloom Energy (BE)
12/23/2019 - 2/4/2020
45.19%
Apellis Pharmaceuticals (APLS)
12/23/2019 - 2/4/2020
44.8%
iRhythm Technologies (IRTC)
12/23/2019 - 2/4/2020
42.55%
Enphase Energy (ENPH)
12/23/2019 - 2/4/2020
42.2%
Soleno Therapeutics (SLNO)
12/23/2019 - 2/4/2020
39.92%
Bill Com (BILL)
12/23/2019 - 2/4/2020
39.21%
Ultragenyx (RARE)
12/23/2019 - 2/4/2020
33.87%
Zai Lab (ZLAB)
12/23/2019 - 2/4/2020
33.72%
Bilibili (BILI)
12/23/2019 - 2/4/2020
31%
Cytokinetics (CYTK)
12/23/2019 - 2/4/2020
29.64%
Celsius (CELH)
12/23/2019 - 2/4/2020
28.77%
Albemarle (ALB)
12/23/2019 - 2/4/2020
28.52%
Bath & Body Works (BBWI)
12/23/2019 - 2/4/2020
27.68%
Api Group  (APG)
12/23/2019 - 2/4/2020
26.93%
Penn National Gaming (PENN)
12/23/2019 - 2/4/2020
26.76%
Wix (WIX)
12/23/2019 - 2/4/2020
26.29%
Sitime (SITM)
12/23/2019 - 2/4/2020
25.23%
Appfolio (APPF)
12/23/2019 - 2/4/2020
25.02%
Orla Mining (ORLA)
12/23/2019 - 2/4/2020
24.74%
Ringcentral (RNG)
12/23/2019 - 2/4/2020
23.76%
Akero Therapeutics (AKRO)
12/23/2019 - 2/4/2020
22.82%
Goosehead Insurance (GSHD)
12/23/2019 - 2/4/2020
22.39%
Mid-cap stocks are treated as having a market cap between $2B and $10B.